title: Stellate cells, a point of light in the dark night of pancreatic cancer.
authors.affiliation: Oncohematology Research Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain.
authors.forename: N
authors.initials: N
authors.lastname: Ramírez
authors.affiliation: Department of Oncology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Viúdez
authors.affiliation: Department of Oncology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Hernández-García
authors.affiliation: Cancer Epigenetics Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Guerrero
authors.affiliation: Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Gómez-Dorronsoro
authors.affiliation: Department of Surgery, Complejo Hospitalario de Navarra, Pamplona, Spain.
authors.forename: F J
authors.initials: FJ
authors.lastname: Herrera
authors.affiliation: Endoscopy Unit, Gastroenterology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Vila
authors.affiliation: Oncohematology Research Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Beloki
authors.affiliation: Oncohematology Research Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Ciaúrriz
authors.affiliation: Oncohematology Research Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Mansilla
authors.affiliation: Department of Oncology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Vera
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D005347:Fibroblasts / Q000473:pathology*; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy*